Revenue: The sum of all revenue fields included for a company's operating activities.
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-235.76M |
|
-- |
|
-- |
|
$201.06M |
|
$-201.06M |
|
$-31.86M |
|
$-232.91M |
|
$-232.91M |
|
$-235.76M |
|
$-235.76M |
|
$-235.76M |
|
$-235.76M |
|
$-201.06M |
|
$-200.11M |
|
114.47M |
|
114.47M |
|
$-2.06 |
|
$-2.06 |
|
| Balance Sheet Financials | |
$536.41M |
|
$0.74M |
|
$40.39M |
|
$576.80M |
|
$58.00M |
|
$108.94M |
|
$117.25M |
|
$175.25M |
|
$401.55M |
|
$401.55M |
|
$401.55M |
|
132.63M |
|
| Cash Flow Statement Financials | |
$-142.06M |
|
$31.27M |
|
$364.75M |
|
$128.03M |
|
$383.22M |
|
$255.19M |
|
$33.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.25 |
|
-- |
|
-- |
|
0.21 |
|
0.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-142.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.71% |
|
-58.71% |
|
-40.87% |
|
-46.18% |
|
$3.03 |
|
$-1.24 |
|
$-1.24 |
|